Literature DB >> 10573435

Cognitive function and endogenous sex hormones in older women.

E Barrett-Connor1, D Goodman-Gruen.   

Abstract

OBJECTIVE: To determine if endogenous hormone levels predict cognitive function in older women.
DESIGN: A longitudinal, population-based study.
SETTING: Rancho Bernardo, California PARTICIPANTS: A total of 393 community-dwelling women aged 55 to 89 years who were not using replacement estrogen.
METHODS: Between 1984 and 1987, sera were collected for measurement of total and bioavailable testosterone, total and bioavailable estradiol, and estrone. Between 1988 and 1991, 12 standard neuropsychological tests were administered, including two items from the Blessed Information-Memory-Concentration Test, three measures of retrieval from the Buschke-Fuld Selective Reminding Test, a category fluency test, immediate and delayed recall from the Visual Reproduction Test, the Mini-Mental State Examination (MMSE) with individual analysis of the Serial 7's and the "World" Backwards components, and the Trail-Making Test part B (Trails B). The association between the five hormones and the 12 cognitive function tests was tested in age- and education-adjusted analyses using linear regression, partial correlation, quintile and categorical analyses.
RESULTS: Women with better MMSE scores (>23) had significantly higher adjusted mean total and bioavailable testosterone levels (P = .009; P = .02, respectively). Using linear regression, the mean total testosterone was significantly associated with better performance on the World component of the MMSE (b = .12; P = .08). With regard to estrogen, the only statistically significant (P = .02) association was better performance on one test in women with very low levels of estradiol.
CONCLUSIONS: In these older women, higher endogenous estrogen levels were not associated with significantly better performance on any cognitive function test. In contrast, higher levels of testosterone predicted better categorical performance on the MMSE and the World component of the MMSE. These novel findings warrant further research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573435     DOI: 10.1111/j.1532-5415.1999.tb07427.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  27 in total

1.  Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats.

Authors:  Joshua S Talboom; Brice J Williams; Edmond R Baxley; Stephen G West; Heather A Bimonte-Nelson
Journal:  Neurobiol Learn Mem       Date:  2008-05-16       Impact factor: 2.877

Review 2.  Aging, estrogens, and episodic memory in women.

Authors:  Victor W Henderson
Journal:  Cogn Behav Neurol       Date:  2009-12       Impact factor: 1.600

3.  Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

4.  Hormonal environment affects cognition independent of age during the menopause transition.

Authors:  Alison Berent-Spillson; Carol C Persad; Tiffany Love; MaryFran Sowers; John F Randolph; Jon-Kar Zubieta; Yolanda R Smith
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

Review 5.  Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases.

Authors:  Mark Preciados; Changwon Yoo; Deodutta Roy
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

Review 6.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

7.  Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.

Authors:  Elizabeth Engler-Chiurazzi; Candy Tsang; Sean Nonnenmacher; Winnie S Liang; Jason J Corneveaux; Laszlo Prokai; Matthew J Huentelman; Heather A Bimonte-Nelson
Journal:  Neurobiol Aging       Date:  2009-11-02       Impact factor: 4.673

Review 8.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 9.  Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials.

Authors:  Elizabeth Barrett-Connor; Gail A Laughlin
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

10.  Androgens protect against apolipoprotein E4-induced cognitive deficits.

Authors:  Jacob Raber; Gerold Bongers; Anthony LeFevour; Manuel Buttini; Lennart Mucke
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.